Clinical trial
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
NCT00346216
Study timeline
Study start (actual)2006-10-04Date precision: day
Registry last updated2021-03-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Arthritis, Rheumatoidunresolved
Interventions
celecoxibDRUG · verified · RxNorm: celecoxib
IbuprofenDRUG · verified · RxNorm: ibuprofen
NaproxenDRUG · verified · RxNorm: naproxen
Sponsors & collaborators
The Cleveland Cliniccollaborator
Mapped research locations
MiamiFlorida, United States15San AntonioTexas, United States14BaltimoreMaryland, United States11HoustonTexas, United States7DallasTexas, United States7TampaFlorida, United States7PhoenixArizona, United States7TucsonArizona, United States7St LouisMissouri, United States6AtlantaGeorgia, United States6ColumbusOhio, United States6OrlandoFlorida, United States6
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00346216 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.